Correction of morphofunctional disorders of the cardiovascular system with asialized erythropoietin and arginase II selective inhibitors KUD 974 and KUD 259 in experimental preeclampsia

Correction of morphofunctional disturbances arising when modelling Preeclampsia with resveratrol and nicorandil

Stupakova, E. G.
Lazareva, G. A.
Gureev, V. V.

January 2018

Preeclampsia is one of the most serious diseases of the second half of pregnancy and is surely among...

Study of the effect of selective inhibitor of arginase II KUD 975 and of low doses of acetylsalicylic acid on the functional parameters of the cardiovascular system In experimental preeclampsia

Severinova, O. V.
Gureev, V. V.
Zhilinkova, L. A.
Lazareva, G. A.
Gureeva, A. V.

May 2020

The article considers study of the effect of selective inhibitor of Arginase II KUD 975 and of low d...

L-NAME-induced preeclampsia: correction of functional disorders of the hemostasis system with resveratrol and nicorandil

Stupakova, E. G.
Lazareva, G. A.
Gureev, V. V.
Dolzhikova, I. N.
Zhilinkova, L. A.

January 2019

Preeclampsia is a formidable disease of the second half of pregnancy, leading to severe complication...

Correction of morphofunctional disorders of the cardiovascular system with asialized erythropoietin and arginase II selective inhibitors KUD 974 and KUD 259 in experimental preeclampsia

Lokteva, Tatyana I.
Rozhkov, l'ya S.
Gureev, Vladimir V.
Gureeva, Anastasia V.
Zatolokina, Marija A.
Avdeeva, Elena V.
Zhilinkova, Lyudmila A.
Prohoda, Evgenij E.
Yarceva, Elizoveta O.

March 2020

Introduction: Preeclampsia remains one of the most common causes of maternal and perinatal mortality...

Study of the effect of selective inhibitor of arginase II KUD 975 and of low doses of acetylsalicylic acid on the functional parameters of the cardiovascular system In experimental preeclampsia

Severinova, O. V.
Gureev, V. V.
Zhilinkova, L. A.
Lazareva, G. A.
Gureeva, A. V.

January 2019

The article considers study of the effect of selective inhibitor of Arginase II KUD 975 and of low d...

Study of the effect of selective inhibitor of arginase II KUD 975 and of low doses of acetylsalicylic acid on the functional parameters of the cardiovascular system In experimental preeclampsia

Severinova, O. V.
Gureev, V. V.
Zhilinkova, L. A.
Lazareva, G. A.
Gureeva, A. V.

January 2019

The article considers study of the effect of selective inhibitor of Arginase II KUD 975 and of low d...

New approaches of morfofunktional pharmacological correction of violations of cardiovascular system in experimental preeclampsia

Gureev, V. V.

January 2016

Experimental Modeling ADMA-like preeclampsia administration to rats was performed by Nnitro-L-argini...

New approaches of morfofunktional pharmacological correction of violations of cardiovascular system in experimental preeclampsia

Gureev, V. V.

January 2016

Experimental Modeling ADMA-like preeclampsia administration to rats was performed by Nnitro-L-argini...

The effect of arginase ii selective inhibitors on the functional parameters of experimental animals in ADMA–like preeclampsia

Severinova, O. V.
Lokteva, T. I.
Gureev, V. V.
Zhernakova, N. I.
Osipova, O. A.
Dolzhikov, A. A.
Pokrovskaya, T. G.

January 2019

Perinatal mortality rate and the rate of preterm birth (10-12%) in pregnant women with hypertensive ...

Correction of morphofunctional disorders with asialoerythropoietin and selective inhibitor of arginase II KUD975 in cases of ischemic kidney damage in the experiment

Elagin, V. V.
Bratchikov, O. I.
Zatolokina, M. A.

January 2018

Acute kidney injury (AKI), which is based on ischemic-reperfusion damage, is a widespread life-threa...

Correction of morphofunctional disorders with asialoerythropoietin and selective inhibitor of arginase II KUD975 in cases of ischemic kidney damage in the experiment

Elagin, V. V.
Bratchikov, O. I.
Zatolokina, M. A.

January 2018

Acute kidney injury (AKI), which is based on ischemic-reperfusion damage, is a widespread life-threa...

Study of the effect of selective inhibitor of Arginase II KUD 975 and of low doses of Acetylsalicylic acid on the functional parameters of the cardiovascular system In experimental preeclampsia

Severinova, Olga V.
Gureev, Vladimir V.
Zhilinkova, Lyudmila A.
Lazareva, Galina A.
Gureeva, Anastasia V.
Lazareva, Sofia S.

December 2019

Introduction: Over the past decade, preeclampsia has been the subject of an increased attention, as ...

NEW APPROACHES OF MORFOFUNKTIONAL PHARMACOLOGICAL CORRECTION OF VIOLATIONS OF CARDIOVASCULAR SYSTEM IN EXPERIMENTAL PREECLAMPSIA

Gureev, Vladimir

September 2016

Experimental Modeling ADMA-like preeclampsia administration to rats was performed by Nnitro-L-argini...

Study of the effect of acetylsalicylic acid and a selective arginase II inhibitor KUD 975 on the correction of hemostatic disorders in experimental preeclampsia

Gureeva, Anastasia V.
Severinova, Olga V.
Gureev, Vladimir V.
Kochkarova, Indira S.
Avdeyeva, Elena V.

July 2022

Introduction: The disruption of the functional state of the vascular endothelium is among the main c...

Correction of morphofunctional disturbances arising when modelling Preeclampsia with resveratrol and nicorandil

Stupakova, E. G.
Lazareva, G. A.
Gureev, V. V.

January 2018

Preeclampsia is one of the most serious diseases of the second half of pregnancy and is surely among...

Correction of morphofunctional disturbances arising when modelling Preeclampsia with resveratrol and nicorandil

Stupakova, E. G.
Lazareva, G. A.
Gureev, V. V.

January 2018

Preeclampsia is one of the most serious diseases of the second half of pregnancy and is surely among...

Study of the effect of selective inhibitor of arginase II KUD 975 and of low doses of acetylsalicylic acid on the functional parameters of the cardiovascular system In experimental preeclampsia

Severinova, O. V.
Gureev, V. V.
Zhilinkova, L. A.
Lazareva, G. A.
Gureeva, A. V.

May 2020

The article considers study of the effect of selective inhibitor of Arginase II KUD 975 and of low d...

L-NAME-induced preeclampsia: correction of functional disorders of the hemostasis system with resveratrol and nicorandil

Stupakova, E. G.
Lazareva, G. A.
Gureev, V. V.
Dolzhikova, I. N.
Zhilinkova, L. A.

January 2019

Preeclampsia is a formidable disease of the second half of pregnancy, leading to severe complication...

Correction of morphofunctional disorders of the cardiovascular system with asialized erythropoietin and arginase II selective inhibitors KUD 974 and KUD 259 in experimental preeclampsia

Lokteva, Tatyana I.
Rozhkov, l'ya S.
Gureev, Vladimir V.
Gureeva, Anastasia V.
Zatolokina, Marija A.
Avdeeva, Elena V.
Zhilinkova, Lyudmila A.
Prohoda, Evgenij E.
Yarceva, Elizoveta O.

March 2020

Introduction: Preeclampsia remains one of the most common causes of maternal and perinatal mortality...

Study of the effect of selective inhibitor of arginase II KUD 975 and of low doses of acetylsalicylic acid on the functional parameters of the cardiovascular system In experimental preeclampsia

Severinova, O. V.
Gureev, V. V.
Zhilinkova, L. A.
Lazareva, G. A.
Gureeva, A. V.

January 2019

The article considers study of the effect of selective inhibitor of Arginase II KUD 975 and of low d...

Study of the effect of selective inhibitor of arginase II KUD 975 and of low doses of acetylsalicylic acid on the functional parameters of the cardiovascular system In experimental preeclampsia

Severinova, O. V.
Gureev, V. V.
Zhilinkova, L. A.
Lazareva, G. A.
Gureeva, A. V.

January 2019

The article considers study of the effect of selective inhibitor of Arginase II KUD 975 and of low d...

New approaches of morfofunktional pharmacological correction of violations of cardiovascular system in experimental preeclampsia

Gureev, V. V.

January 2016

Experimental Modeling ADMA-like preeclampsia administration to rats was performed by Nnitro-L-argini...

New approaches of morfofunktional pharmacological correction of violations of cardiovascular system in experimental preeclampsia

Gureev, V. V.

January 2016

Experimental Modeling ADMA-like preeclampsia administration to rats was performed by Nnitro-L-argini...

The effect of arginase ii selective inhibitors on the functional parameters of experimental animals in ADMA–like preeclampsia

Severinova, O. V.
Lokteva, T. I.
Gureev, V. V.
Zhernakova, N. I.
Osipova, O. A.
Dolzhikov, A. A.
Pokrovskaya, T. G.

January 2019

Perinatal mortality rate and the rate of preterm birth (10-12%) in pregnant women with hypertensive ...

Correction of morphofunctional disorders with asialoerythropoietin and selective inhibitor of arginase II KUD975 in cases of ischemic kidney damage in the experiment

Elagin, V. V.
Bratchikov, O. I.
Zatolokina, M. A.

January 2018

Acute kidney injury (AKI), which is based on ischemic-reperfusion damage, is a widespread life-threa...

Correction of morphofunctional disorders with asialoerythropoietin and selective inhibitor of arginase II KUD975 in cases of ischemic kidney damage in the experiment

Elagin, V. V.
Bratchikov, O. I.
Zatolokina, M. A.

January 2018

Acute kidney injury (AKI), which is based on ischemic-reperfusion damage, is a widespread life-threa...

Study of the effect of selective inhibitor of Arginase II KUD 975 and of low doses of Acetylsalicylic acid on the functional parameters of the cardiovascular system In experimental preeclampsia

Severinova, Olga V.
Gureev, Vladimir V.
Zhilinkova, Lyudmila A.
Lazareva, Galina A.
Gureeva, Anastasia V.
Lazareva, Sofia S.

December 2019

Introduction: Over the past decade, preeclampsia has been the subject of an increased attention, as ...

NEW APPROACHES OF MORFOFUNKTIONAL PHARMACOLOGICAL CORRECTION OF VIOLATIONS OF CARDIOVASCULAR SYSTEM IN EXPERIMENTAL PREECLAMPSIA

Gureev, Vladimir

September 2016

Experimental Modeling ADMA-like preeclampsia administration to rats was performed by Nnitro-L-argini...

Study of the effect of acetylsalicylic acid and a selective arginase II inhibitor KUD 975 on the correction of hemostatic disorders in experimental preeclampsia

Gureeva, Anastasia V.
Severinova, Olga V.
Gureev, Vladimir V.
Kochkarova, Indira S.
Avdeyeva, Elena V.

July 2022

Introduction: The disruption of the functional state of the vascular endothelium is among the main c...

Correction of morphofunctional disturbances arising when modelling Preeclampsia with resveratrol and nicorandil

Stupakova, E. G.
Lazareva, G. A.
Gureev, V. V.

January 2018

Preeclampsia is one of the most serious diseases of the second half of pregnancy and is surely among...

Correction of morphofunctional disturbances arising when modelling Preeclampsia with resveratrol and nicorandil

Stupakova, E. G.
Lazareva, G. A.
Gureev, V. V.

January 2018

Preeclampsia is one of the most serious diseases of the second half of pregnancy and is surely among...

Study of the effect of selective inhibitor of arginase II KUD 975 and of low doses of acetylsalicylic acid on the functional parameters of the cardiovascular system In experimental preeclampsia

Severinova, O. V.
Gureev, V. V.
Zhilinkova, L. A.
Lazareva, G. A.
Gureeva, A. V.

May 2020

The article considers study of the effect of selective inhibitor of Arginase II KUD 975 and of low d...

L-NAME-induced preeclampsia: correction of functional disorders of the hemostasis system with resveratrol and nicorandil

Stupakova, E. G.
Lazareva, G. A.
Gureev, V. V.
Dolzhikova, I. N.
Zhilinkova, L. A.

January 2019

Preeclampsia is a formidable disease of the second half of pregnancy, leading to severe complication...

Correction of morphofunctional disorders of the cardiovascular system with asialized erythropoietin and arginase II selective inhibitors KUD 974 and KUD 259 in experimental preeclampsia

Abstract

Extracted data

Correction of morphofunctional disorders of the cardiovascular system with asialized erythropoietin and arginase II selective inhibitors KUD 974 and KUD 259 in experimental preeclampsia

Abstract

Extracted data

Related items

Related items